Suppr超能文献

健康机会成本的估算是否被用于在已发表的成本效益分析中得出结论?四个国家的范围综述

Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries.

机构信息

Departamento de Métodos Cuantitativos en Economía y Gestión, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.

Kronikgune Institute for Health Services Research, Barakaldo, Basque Country, Spain.

出版信息

Appl Health Econ Health Policy. 2022 May;20(3):337-349. doi: 10.1007/s40258-021-00707-8. Epub 2021 Dec 29.

Abstract

BACKGROUND

When healthcare budgets are exogenous, cost-effectiveness thresholds (CETs) used to inform funding decisions should represent the health opportunity cost (HOC) of such funding decisions, but HOC-based CET estimates have not been available until recently. In recent years, empirical HOC-based CETs for multiple countries have been published, but the use of these CETs in the cost-effectiveness analysis (CEA) literature has not been investigated. Analysis of the use of HOC-based CETs by researchers undertaking CEAs in countries with different decision-making contexts will provide valuable insights to further understand barriers and facilitators to the acceptance and use of HOC-based CETs.

OBJECTIVES

We aimed to identify the CET values used to interpret the results of CEAs published in the scientific literature before and after the publication of jurisdiction-specific empirical HOC-based CETs in four countries.

METHODS

We undertook a scoping review of CEAs published in Spain, Australia, the Netherlands and South Africa between 2016 (2014 in Spain) and 2020. CETs used before and after publication of HOC estimates were recorded. We conducted logit regressions exploring factors explaining the use of HOC values in identified studies and linear models exploring the association of the reported CET value with study characteristics and results.

RESULTS

1171 studies were included in this review (870 CEAs and 301 study protocols). HOC values were cited in 28% of CEAs in Spain and in 11% of studies conducted in Australia, but they were not referred to in CEAs undertaken in the Netherlands and South Africa. Regression analyses on Spanish and Australian studies indicate that more recent studies, studies without a conflict of interest and studies estimating an incremental cost-effectiveness ratio (ICER) below the HOC value were more likely to use the HOC as a threshold reference. In addition, we found a small but significant impact indicating that for every dollar increase in the estimated ICER, the reported CET increased by US$0.015. Based on the findings of our review, we discuss the potential factors that might explain the lack of adoption of HOC-based CETs in the empirical CEA literature.

CONCLUSIONS

The adoption of HOC-based CETs by identified published CEAs has been uneven across the four analysed countries, most likely due to underlying differences in their decision-making processes. Our results also reinforce a previous finding indicating that CETs might be endogenously selected to fit authors' conclusions.

摘要

背景

当医疗保健预算是外生的时,用于为决策提供信息的成本效益阈值(CET)应代表此类决策的健康机会成本(HOC),但直到最近才出现基于 HOC 的 CET 估计。近年来,多个国家已经公布了基于经验的 HOC 为基础的 CET,但这些 CET 在成本效益分析(CEA)文献中的使用尚未得到研究。对在具有不同决策背景的国家开展 CEA 的研究人员使用基于 HOC 的 CET 的情况进行分析,将为进一步了解接受和使用基于 HOC 的 CET 的障碍和促进因素提供有价值的见解。

目的

我们旨在确定在西班牙、澳大利亚、荷兰和南非四个国家公布特定管辖权基于经验的 HOC 为基础的 CET 之前和之后,在科学文献中发表的 CEA 中使用的 CET 值。

方法

我们对 2016 年(西班牙为 2014 年)至 2020 年期间在西班牙、澳大利亚、荷兰和南非发表的 CEA 进行了范围综述。记录了在公布 HOC 估计值之前和之后使用的 CET 值。我们进行了逻辑回归分析,以探讨解释确定研究中使用 HOC 值的因素,并进行了线性模型分析,以探讨报告的 CET 值与研究特征和结果的关联。

结果

本综述共纳入 1171 项研究(870 项 CEA 和 301 项研究方案)。在西班牙的 CEA 中,有 28%的研究提到了 HOC 值,而在澳大利亚的研究中则有 11%的研究提到了 HOC 值,但在荷兰和南非的 CEA 中并未提及 HOC 值。对西班牙和澳大利亚的研究进行回归分析表明,更新的研究、没有利益冲突的研究和估计增量成本效益比(ICER)低于 HOC 值的研究更有可能将 HOC 用作阈值参考。此外,我们发现了一个很小但有意义的影响,即估计的 ICER 每增加 1 美元,报告的 CET 值就增加 0.015 美元。基于我们的综述结果,我们讨论了可能解释为什么在经验性 CEA 文献中没有采用基于 HOC 的 CET 的潜在因素。

结论

在所分析的四个国家中,已发表的 CEA 对基于 HOC 的 CET 的采用参差不齐,这很可能是由于其决策过程存在潜在差异所致。我们的结果还进一步证实了先前的发现,即 CET 可能是内源性选择的,以符合作者的结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178b/9021093/90e338c4e15a/40258_2021_707_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验